Profiling of miRNAs and target genes related to cystogenesis in ADPKD mouse models by 복진웅 & 신정오
1Scientific RepoRts | 7: 14151  | DOI:10.1038/s41598-017-14083-8
www.nature.com/scientificreports
Profiling of miRNAs and target 
genes related to cystogenesis in 
ADPKD mouse models
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Eun Young Park1, Jinwoong Bok4 & Jong Hoon Park  1
Autosomal polycystic kidney disease (ADPKD) is a common inherited renal disease characterized by 
the development of numerous fluid-filled cysts in both kidneys. We investigated miRNA-mediated 
regulatory systems and networks that play an important role during cystogenesis through integrative 
analysis of miRNA- and RNA-seq using two ADPKD mouse models (conditional Pkd1- or Pkd2-deficient 
mice), at three different time points (P1, P3, and P7). At each time point, we identified 13 differentially 
expressed miRNAs (DEmiRs) and their potential targets in agreement with cyst progression in both 
mouse models. These targets were involved in well-known signaling pathways linked to cystogenesis. 
More specifically, we found that the actin cytoskeleton pathway was highly enriched and connected 
with other well-known pathways of ADPKD. We verified that miR-182-5p regulates actin cytoskeleton 
rearrangement and promotes ADPKD cystogenesis by repressing its target genes—Wasf2, Dock1, 
and Itga4—in vitro and in vivo. Our data suggest that actin cytoskeleton may play an important role 
in renal cystogenesis, and miR-182-5p is a novel regulator of actin cytoskeleton and cyst progression. 
Furthermore, this study provides a systemic network of both key miRNAs and their targets associated 
with cyst growth in ADPKD.
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited renal disorder, char-
acterized by the development of numerous fluid-filled cysts. It is caused by mutations in either PKD1 (approxi-
mately 85% of cases) or PKD2 (approximately 15% of cases)1. Reduced dosage of Polycystin (PC) 1, the protein 
encoded by the PKD1 gene, can lead to the clinical features of ADPKD2. Recently, whole-exome sequencing 
identified mutation in GANAB, encoding glucosidase II subunit α (GIIα), cause ADPKD and liver disease3. 
Cyst initiation and enlargement arise from disturbances in the balance between tubular cell proliferation and 
apoptosis, alterations in the cell polarity of membrane proteins, extracellular matrix defects, abnormal fluid 
secretion, and abnormal ciliary function, which induces kidney enlargement and interstitial fibrosis4,5. Although 
many pathways are involved in ADPKD, including Ca2+, cAMP, Wnt, JAK2/STAT1/p21, ERK, and mTOR6–10, 
an assumption questioned by several recent studies suggests an unrevealed signaling pathway to be the fatal 
cause11–15. Indeed, the severity of renal disease is highly variable even within the same family and among patients 
with ADPKD. Therefore, increasing evidence suggests a critical role for epigenetic modifications as another risk 
factor in cystogenesis.
Cell migration plays a key role in many physiological and pathological processes. Migratory stimuli induce 
a multistep cell migration process, which first involves the acquisition of a characteristic polarized morphol-
ogy toward the stimulus, called the leading edge. At the leading edge, flat membrane protrusions, lamellipo-
dia, and finger-like protrusions, filopodia, are formed by actin polymerization16. Activated N-WASP/WAVE and 
Arp2/3 proteins induce nucleation of a branched actin network at the lamellipodium17. In particular, both PC1 
and Pacsin2 co-localize on the lamellipodia of migrating kidney epithelial cells, and are required for N-Wasp/
Arp2/3-dependent actin remodeling as members of the same protein complex18. However, direct mechanisms 
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that cause defective actin cytoskeleton function during cyst formation and enlargement in PKD disease models 
have not been elucidated.
MicroRNAs (miRNAs) are small, regulatory, non-coding RNAs that negatively regulate multiple 
protein-coding genes by binding seed sequences in their 3′UTRs19,20. Recent studies have revealed that miRNAs 
are closely associated with cystogenesis in ADPKD21. Mice lacking Dicer, a key enzyme in miRNA biogenesis, in 
renal tubules and collecting ducts showed defects in kidney tubule maturation such as hydronephrosis, hydro-
ureter, and cyst formation22. Additionally, the upregulation of several miRNAs, including the miR-17/92 miRNA 
cluster and miR-21, accelerates renal cyst development in ADPKD mouse models23,24.
Constitutive Pkd1- or Pkd2-targeted knockout mouse models show embryonic lethality with renal cysts, liver 
cysts, cardiovascular defects, and dysregulated skeletal development25. However, Pkd1 or Pkd2 conditional knock-
out mice, which are kidney-specifically deficient, are born normally and show rapid cyst formation from postna-
tal day 1 (P1), accompanied by increased cell proliferation by abnormal activation of the MAPK/ERK pathway26. 
Herein, we used kidney collecting-duct-specific Cre-expressing mice for Pkd1 or Pkd2 conditional inactivation.
In this study, we investigated miRNA profiles associated with severity of cyst development in the ADPKD 
models of Pkd1 or Pkd2 conditional knockout mice. From the parallel analysis of miRNA-sequencing and 
RNA-sequencing, we identified key miRNAs and their targets that are involved in the actin cytoskeleton pathway, 
a novel cystogenesis-related signaling mechanism.
Results
Cyst formation derived from HoxB7-cre-mediated inactivation of the Pkd1flox allele. To investi-
gate detailed phenotypic changes resulting from the collecting-duct-specific inactivation of either Pkd1 or Pkd2, 
kidney samples were collected and cyst formation and renal function were investigated at postnatal day 1 (P1), 
P3, and P7 in each rodent model. Immunofluorescence showed that most cysts were derived from the collecting 
duct. To identify the origin of renal tubular cysts, nephron segment-specific markers were used. In Pkd1- or Pkd2-
deficient mice, all dilated tubules and cysts lining epithelial cells stained positively for Dolichos biflorus agglutinin 
(DBA), which is specifically expressed in the collecting duct. In contrast, none of the cysts stained positively for 
Lotus tetragonolobus lectin (LTL), a proximal tubule marker (Supplementary Fig. S1). Several dilated tubules 
were observed in both kidneys from Pkd1f/f:HoxB7-cre mice at P1 and occasional cyst formation was observed 
starting at P3 in these mice. After P3, cyst size and kidney volume were rapidly increased. In particular, loss of 
renal function was observed in P7 Pkd1f/f:HoxB7-cre mice (Fig. 1A–D). Pkd2f/f:HoxB7-cre mice also showed 
Figure 1. Characterization of mice with kidney collecting duct-specific Pkd1 knockout. (A) The whole 
kidney sections from mice at postnatal day 1 (P1), P3, and P7 were stained with the collecting duct-specific 
marker Dolichos biflorus agglutinin (DBA, red) and the proximal tubule marker Lotus tetragonolobus lectin 
(LTL, green). Nuclei were counterstained with DAPI (blue). (B) The areas of cysts derived from collecting 
ducts were measured and classified by cyst sizes: non-cystic area, dilated tubules (<1 × 105 μm2), small cysts 
(1 × 105–106 μm2), and large cysts (>1 × 106 μm2). (C) Kidney/body weight ratio and (D) serum urea nitrogen 
(BUN) concentration in Pkd1f/f versus Pkd1f/f:HoxB7-Cre mice. Data are shown as mean ± SD; n ≥ 10 for each 
time point; *P < 0.05; **P < 0.01; ***P < 0.001. (E) Survival rate curves of Pkd1f/f versus Pkd1f/f:HoxB7-Cre 
mice. n ≥ 10.
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phenotypic changes similar to those in Pkd1f/f:HoxB7-cre mice (Supplementary Fig. S2), except for survival rate, 
which indicated longer survival in Pkd2f/f:HoxB7-cre mice than in Pkd1f/f:HoxB7-cre mice (Fig. 1E). These data 
suggested that conditional inactivation of Pkd1- or Pkd2 may share common cyst formation processes in early 
stages, but different cyst expansion processes in later stages.
Integrated analysis of miRNA-seq and mRNA-seq. Given the phenotypic changes, both miRNA-seq 
and RNA-seq analyses were carried out using kidney tissues from the two mouse models at the indicated time 
points (P1, P3, and P7, n = 3). An integrative analysis of both types of NGS data was performed as shown in 
Supplementary Fig. S3. To profile transcripts and their expressions, we measured read counts instead of RPKM27 
or FPKM28 values, because this was a more accurate measure for comparing differences between the mouse mod-
els at indicated time points29. miRNA expression was also measured based on known sequences. The read count 
values for each mouse model were normalized and used for further analysis. To enhance the candidate pools 
of mRNAs and miRNAs, mRNAs and miRNAs showing negative binomial distributions were identified inde-
pendently and correlation analysis between mRNAs and miRNAs were performed. First, the most popular two 
methods (edgeR30 and Deseq. 231) were performed in both wild-type (WT; Pkd1f/f and Pkd2f/f) and knockout 
(KO; Pkd1f/f:HoxB7-cre and Pkd2f/f:HoxB7-cre) models to identify significantly differentially expressed mRNAs 
and miRNAs. For RNA-seq analysis, 3,040 transcripts in Pkd1f/f:HoxB7-cre mice and 2,470 transcripts in Pkd2f/f: 
HoxB7-cre mice were differentially expressed at the indicated time points (FDR < 0.05). In addition, we also 
identified 1,297 commonly regulated transcripts in both mouse models. For miRNA analysis, 243 miRNAs were 
differentially expressed, while 130 miRNAs were common in both mouse models (Supplementary Tables S1, 2, 
3 and 4). Among the common miRNAs, 13 miRNAs, including 11 upregulated and two downregulated miRNAs 
(Fig. 2A), were selected based on expression pattern comparison at each time point. Second, correlation analysis 
was carried out using 13 DEmiRs and differentially expressed genes (DEGs) in both mouse models. Then, path-
way analysis was performed and well-known pathways involved in cystogenesis including ERK/MAPK, AKT/
mTOR, JAK/STAT, Wnt/β-catenin, PCP pathway, cell cycle, and TGF-β signaling pathways were identified along 
with novel pathways, such as the actin cytoskeleton pathway. miRNAs in the actin cytoskeleton pathway were 
highly enriched and delicately connected with other well-known signaling pathways (Supplementary Tables S5 
and S6). Expression of candidate DEmiR targets associated with the actin cytoskeleton were gradually changed 
along with cyst progression in Pkd1f/f:HoxB7-cre mice (Fig. 2B). Remarkably, miR-182-5p had multiple candidate 
targets involved in actin cytoskeleton signaling (Fig. 2C). The data indicated that 13 miRNAs were commonly 
associated with cystogenesis-related pathways, although they may target different mRNAs in two mouse models 
of ADPKD.
Figure 2. Correlation between cystogenesis-regulated miRNAs and candidate target mRNAs to the actin 
cytoskeleton. (A) Heat map of 13 differentially expressed miRNAs (DEmiRs) which were commonly changed 
in kidneys of both Pkd1f/f:HoxB7-Cre and Pkd2f/f:HoxB7-Cre mice for each time point. (B) Heat map displaying 
the differentially expressed mRNAs which are candidate targets of the 13 common DEmiRs from both mouse 
models and related with actin cytoskeleton signaling in Pkd1f/f:HoxB7-Cre mice. (C) Interactive network 
between 13 DEmiRs and differentially expressed mRNAs associated with the actin cytoskeleton signaling 
pathway.
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Validation of key miRNAs and candidate target genes. To validate the correlation analysis, expres-
sion levels of 13 key miRNAs were confirmed in the kidney tissues of Pkd1f/f:HoxB7-cre mice using qRT-PCR. 
Most miRNAs, including miR-182-5p, showed a similar expression pattern between qRT-PCR and sequencing 
results (Fig. 3A). Interestingly, we observed that all miR-182 family members, miR-182-3p, miR-182-5p, miR-
183-5p, and miR-96-5p, were significantly upregulated in P7 Pkd1f/f:HoxB7-cre mice kidney tissues. Upon 
considering both small RNA-seq raw data and qRT-PCR, we concluded that miR-182-5p was the most suitable 
subject for future research. To identify alterations of spatiotemporal miR-182-5p expression in the mouse post-
natal kidney, section miRNA in situ hybridization (ISH) was performed. Expression of miR-182-5p was detected 
in the Pkd1f/f medulla region and glomerulus. Interestingly, miR-182-5p-expressing cells were observed in the 
cuboidal epithelial lining cells of the cyst in Pkd1f/f:HoxB7-Cre mice at P7 (Fig. 3B). miR-182-5p was localized in 
the overall kidney region at P1 and P3, including the medulla and cortex regions (Supplementary Fig. S4). The 
glomerulus showed especially strong miR-182-5p expression in P1 Pkd1f/f mice (Supplementary Fig. S4A–C). In 
the Pkd1f/f:HoxB7-Cre mice, as expected, miR-182-5p was strongly expressed in the cyst-lining epithelial cells 
(Supplementary Fig. S4D–F and J–L). In Pkd1f/f at P3, interestingly, miR-182-5p expression was observed in the 
renal tubule domain, but the glomerulus and Bowman’s capsule cells did not exhibit miR-182-5p-expressing cells 
(Supplementary Fig. S4G–I). Candidate target mRNAs of miR-182-5p were downregulated in the kidney tissues 
of Pkd1f/f:HoxB7-cre mice over time (Fig. 3C and Supplementary Fig. S5A). Furthermore, the expression of genes 
involved in ERK/MAPK and AKT/mTOR signaling pathways was increased; these pathways regulate cell prolif-
eration in ADPKD (Supplementary Fig. S6A and C). Indeed, when we examined cell proliferation at the three 
time-points by ki67 staining, proliferating cells were markedly observed in cyst-lining cells of both KO mouse 
models, but not in WT kidney tissues (Supplementary Fig. S6B,D and E). In particular, in order to investigate the 
link between miR-182-5p and targets involved in actin cytoskeleton signaling as a novel cystogenesis pathway, a 
3′UTR luciferase assay for miR-182-5p was performed. We found that miR-182-5p directly bound to the 3′UTR 
of these candidate target mRNAs related to actin cytoskeleton, negatively regulating their translation (Fig. 3D 
and Supplementary Fig. S5B). Therefore, our results were consistent with those of previous studies and helped us 
identify miRNAs that bridge ADPKD actin cytoskeleton defects and cystogenesis.
Cyst formation upon actin cytoskeleton defects. The overexpression of PC1 induces cytoskeletal rear-
rangement, cell migration, and tubule formation32. To evaluate the relevance of this protein to the actin cytoskel-
eton in ADPKD cystogenesis, 3-dimensional (3D) culture and F-actin staining were performed after knockdown 
of either Pkd1 or Pkd2 in mouse inner medullary collecting duct (mIMCD) cells. Prior to staining, mRNA and 
protein levels of Pkd1, Pkd2, and miR-182-5p target genes were determined in recovered mIMCD spheroids 
(Supplementary Fig. S7). Knockdown of either Pkd1 or Pkd2 in mIMCD cells resulted in remarkable defects 
of F-actin structure and accelerated cyst growth in 3D culture (Fig. 4A). In this study, we utilized two collect-
ing duct-specific polycystin-1 knockout mouse models, Pkd1f/f:HoxB7-cre and Pkd1f/f:Aqp2-cre; two different 
promoters were used to drive Cre recombinase expression in the transgenic mice. Although Pkd1f/f:HoxB7-cre 
mice and Pkd1f/f:Aqp2-cre mice have similar PKD phenotypes, Pkd1f/f:Aqp2-cre mice tend to survive longer 
than Pkd1f/f:HoxB7-cre mice33. Upon staining these cells with both rhodamine-labeled phalloidin and marker 
genes related to the actin cytoskeleton in wild-type (Pkd1f/f) and Pkd1-deficient (Pkd1f/f:Aqp2-cre and Pkd1f/
f:HoxB7-cre) mouse kidneys, strong F-actin signals were observed in the apical membrane with weak signals out-
lining the tubules in WT kidneys. However, cyst-lining epithelial cells in Pkd1-deficient kidneys showed reduced 
and disorganized actin cytoskeletons with significantly decreased levels of marker genes such as Wasf2, Dock1, 
and Itga4 (Fig. 4B and Supplementary Fig. S8). To investigate whether actin filament polymerization was involved 
in cyst development, actin structures were investigated after a wound healing assay. Five hours after scratching, 
cells deficient in Wasf2, Dock1, or Itga4 did not produce organized actin cytoskeletons like those observed in 
the control siRNA-transfected cells (Fig. 4C). In addition, knocking down Wasf2, Dock1, or Itga4 promoted cyst 
growth with actin cytoskeleton defects in 3D culture conditions (Fig. 4D). Moreover, western blotting analysis 
revealed that miR-182-5p negatively regulated the target genes Wasf2, Dock1, and Itga4 (Fig. 5A). Intriguingly, 
we found that overexpressing miR-182-5p inhibits actin cytoskeleton organization, particularly lamellipodium 
formation, by repressing marker genes related with the actin cytoskeleton, ultimately affecting cyst development 
in vitro (Fig. 5B and C). Finally, overexpressing miR-182-5p increased cyst growth, while inhibiting miR-182-5p 
inhibited cyst formation (Fig. 5C). These data suggest that miR-182-5p may play a critical role as a novel inducer 
of cystogenesis by regulating the actin cytoskeleton.
Inhibiting miR-182-5p attenuates cyst growth in a Pkd1 conditional knockout mouse model. 
To evaluate the therapeutic effect of miR-182-5p inhibition, a lentiviral particle-mediated miRNA inhibition 
system was introduced. The Pkd1f/f:Aqp2-cre mouse model was selected for the injection study because Pkd1f/
f:HoxB7-cre mice live for only 14–23 days. A control lentivirus or inhibitory miR-182-5p lentiviral particles (final 
conc.: 4 × 107 IU) were injected intraperitoneally five times on alternate days. Mice were then sacrificed the day 
after the final injection (Fig. 6A). Kidney weight-to-body weight ratios, BUN levels, and miR-182-5p expression 
in kidney tissues were reduced upon treatment with the inhibitory miR-182-5p lentivirus compared with those 
in con-lentivirus-treated Pkd1f/f:Aqp2-cre mice (Fig. 6B–E). Furthermore, we observed that the expression pat-
terns of the target genes of miR-182-5p, Wasf2, Dock1, and Itga4, were restored in mice treated with inhibitory 
miR-182-5p lentivirus (Fig. 6F). Collectively, these results indicated that inhibiting miR-182-5p was effective for 
inhibiting cyst growth and restoring renal function.
Discussion
In the current study, we described parallel integrated analysis of miRNA-seq and RNA-seq data and validated the 
expression, direct interaction, and cystogenesis-related functions of key miRNAs and their targets. In particular, 
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Figure 3. Expression validation of key miRNAs and target mRNAs in kidney tissues of Pkd1 conditional knockout 
mice. (A) The expression level of 13 key miRNAs and (C) candidate target mRNAs of miR-182-5p were confirmed in 
kidneys of Pkd1f/f:HoxB7-Cre at P1, P3, and P7 using quantitative real-time RT-PCR. Target mRNAs included genes 
related with cystogenesis and the actin cytoskeleton (Wasf2, Dock1, Itga4). RNU6 and 18s rRNA were used as internal 
controls for miRNA and mRNA, respectively. The experiment was performed in triplicate. n ≥ 3 for each time point. 
(B) Alteration of miR-182-5p expression in Pkd1f/f:HoxB7-Cre mouse kidney at P7. At P7, the expression pattern of 
miR-182-5p is detected by section in situ hybridization (ISH) in Pkd1f/f and Pkd1f/f:HoxB7-Cre mice. M, medulla; C, 
cortex; G, glomerulus; Cy, cyst; black arrow, miR-182-expressing glomerulus; black dotted box, high magnification 
region; red dotted line, cyst lining epithelial cells. scale bars indicate left 200 µm; middle 100 µm; right 50 µm. (D) 
Relative 3′UTR luciferase activity of Wasf2, Dock1, and Itga4 genes upon transfecting mIMCD cells with Negative 
Control mimic (NC mimic) or miR-182-5p mimic. Mutating the seed sequence of miR-182-5p induced rescued 
luciferase activity of the psiCHECK-2 vector. WT (wild type), MT (mutant type). Data are presented as mean ± SD of 
three independent experiment in triplicate. ***P < 0.001; **P < 0.01.
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we found commonly dysregulated pathways by comparing Pkd1- and Pkd2-deficient mouse models. These mod-
els had overlapping, differentially expressed miRNAs and signaling pathways related with cystogenesis, suggest-
ing that these miRNAs play crucial roles in cyst formation and expansion in ADPKD patients with either PKD1 
or PKD2 mutations. Although both mouse models have common key miRNAs, these miRNAs are considered 
to target different mRNAs in Pkd1 and Pkd2-deficient mice (Supplementary Fig. S9). Indeed, our data showed 
that miR-182-5p was associated with cystogenesis by regulating the actin cytoskeleton signaling pathway in both 
mouse models. However, miR-182-5p directly targets and regulates Wasf2, Dock1, and Itga4 in Pkd1-deficient 
mice, but not in Pkd2-deficient mice (Supplementary Fig. S10). This difference may be related to their pheno-
typic differences: even though these two models showed similar cyst progression and timing of renal failure, 
Pkd2-deficient mice remained alive longer than Pkd1-deficient mice, for maximum of about 20 days. This sug-
gests that these mouse models share common molecular alterations in early stage cystogenesis but they have 
specific molecular changes in late stages, at least after P7. Therefore, our data showed that defects in Pkd1 or 
Pkd2 share some, but not all, molecular changes and signaling pathways. Moreover, the parallel analysis between 
time-dependent phenotypic characterization and miRNA-mRNA profiling allowed us to select and validate more 
precise targets involved in ADPKD cyst progression.
Recently, there have been several miRNA profiling studies in ADPKD rodent models, using microarrays. 
Pandey et al. performed global gene-expression profiling by microarray in Pkd1−/− embryonic kidneys at 
P14.5 and 17.5 and predicted miRNAs through computational approaches34. They confirmed nine candidate 
Figure 4. Defects in the actin cytoskeleton promote cyst development and growth. (A,D) Pkd1, Pkd2, Wasf2, 
Dock1, and Itga4 siRNA-transfected mIMCD cells showed formed larger cysts than control siRNA-transfected 
mIMCD cells did. After 6 days of mIMCD culture in matrigel, representative images were obtained and cyst 
lumen sizes were randomly measured in mIMCD spheroids. Each spheroid was stained with rhodamine-labeled 
phalloidin (red) for F-actin. Nuclei were counterstained with DAPI (blue). (B) Expression of Wasf2, Dock1, 
and Itga4 protein (red) was analyzed by immunofluorescence in kidneys of Pkd1f/f and Pkd1f/f:HoxB7-Cre mice. 
These target proteins were significantly repressed in collecting duct-specific cyst lining epithelial cells (green), 
but not in normal tubules. Cy, cyst. Scale bar indicates 20 μm. (C) Five hours after scratching, mIMCD cells 
transfected with siRNAs for Wasf2, Dock1, or Itga4 formed fewer lamellipodia and reduced expression of actin 
cytoskeleton proteins on lamellipodia at the leading edge compared with either control siRNA- or negative 
control mimic-transfected cells. Scale bars represent 25 μm (in the smaller square) and 75 μm. *P < 0.05; 
**P < 0.01; ***P < 0.001.
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miRNAs, including miR-182 and miR-96, by qPCR and suggested that several miRNAs may be associated 
with ADPKD-related signaling pathways. Dweep et al. identified eight significantly upregulated miRNAs in 
diseased kidneys of PKD/Mhm rats by a parallel microarray-based approach35. A major advantage of unbi-
ased next-generation sequencing-based approaches such as small RNA-seq and RNA-seq is that they provide 
genome-wide and quantitative information, whereas microarray-based approaches do not. Our results are par-
tially in agreement with two previous studies but have different candidate miRNAs and targeting signaling path-
ways. Although it is well-known that increased proliferation by pathways including ERK/MAPK is required for 
cyst formation, the precise mechanism of cyst formation and enlargement in ADPKD has not yet been described. 
This indicates that systemic analysis is necessary for uncovering novel relevant pathways. From integrated 
miRNA-seq and RNA-seq analysis, we observed that Pkd1 inactivation changes the expression of several key 
miRNAs involved in previously reported signaling pathways such as ERK/MAPK and Akt/mTOR signaling, as 
well a novel pathway, actin cytoskeleton signaling. In addition, our data showed that upregulation of miR-21a-5p 
in cyst-lining epithelial cells stimulates cyst growth in Pkd1-deficient mice, consistent with a previous study23.
Intriguingly, we provided evidence of a direct link between the actin cytoskeleton and cystogenesis in 
ADPKD. In a previous study, polycystins were found to be responsible for cell migration, polarity, and tissue 
morphogenesis36. PC1 regulates the actin cytoskeleton and cell migration mediated by the phosphatidylinositol 
3-kinase (PI3-K) pathway in MDCK cells32. The PI3-K pathway was significantly enriched in diseased kidneys of 
Pkd1-deficient mice, suggesting that the downregulation of PI3K genes such as Pik3r1 and Pik3r3 may be asso-
ciated with actin cytoskeleton defects and reduced migration capacity in cystic epithelial cells. In addition, PC1 
is involved in the actin cytoskeleton by interacting with the Pacsin/WASP-2/Arp2/3 complex, which contributes 
to microfilament nucleation at the leading edge18. However, these two studies did not show direct evidence link-
ing the actin cytoskeleton with cyst development. From our results, we identified that key proteins involved in 
the actin cytoskeleton were regulated by several miRNAs, including miR-182-5p, that control cyst progression. 
Wasf2, also known as Wave2, is a well-known key component of the actin regulatory machinery and mediates 
Figure 5. Role of miR-182-5p in renal cystogenesis linked to defects in the actin cytoskeleton. (A) Altered 
protein expression levels observed upon transfection of mIMCD cells with miR-182-5p mimic or miR-182-5p 
inhibitor were confirmed by western blot analysis. β-Actin was used as an internal control. Each experiment was 
performed in triplicate. (B) Pictures were taken five hours after scratching. Ectopic expression of miR-182-5p 
prevented the reorganization of actin filaments in mIMCD cells. Scale bars represent 25 μm (in the smaller 
square), and 75 μm. (C) miR-182-5p precursors or inhibitors (20 nM) were transfected into mIMCD cells, and 
then cells were observed in 3D culture conditions. The cysts in miR-182-5p precursor-treated cells were bigger 
than cysts in NC treated cells. miR-182-5p inhibitor-transfected mIMCD cells showed reduced of cyst lumen 
size. Immunostaining with Wasf2, Dock1, and Itga4 (green); F-actin (red); DAPI (blue). ***P < 0.001.
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actin cytoskeletal organization by cooperating with the Arp2/3 complex to promote the formation of actin fila-
ments37. We identified, Wasf2 as a novel direct target of miR-182-5p. Inhibiting Wasf2 expression accelerated cyst 
growth, dysregulated actin structure, and decreased cell migration. We also found that Dock1 is a novel direct 
target of miR-182-5p. Dock1 is a guanine nucleotide exchange factor that activates the Rac1/WAVE-complex/
Arp2/3-complex, resulting in the formation of lamellipodial protrusions38. We observed that Dock1 repression 
also stimulated cyst development via alterations of the actin structure in mIMCD 3D cultures. Taken together, 
the results suggest that defects in the actin cytoskeleton and progression of cyst formation are tightly linked. 
Furthermore, actin dynamics seem to be linked to establishment of cell polarity and formation of apical junc-
tions39. Defects in cell/matrix interaction is a suggested causative mechanism of cystogenesis in ADPKD, but 
these remain poorly understood. Integrins are the main cell surface receptors for proteins within the extracellular 
matrix (ECM)40. They contribute to cell movement and mediate adhesion junctions, which are essential for tissue 
integrity41. Integrin alpha 4 (Itga4), which we identified as a novel target of miR-182-5p, may play a crucial role in 
migratory events and we showed that it can affect cyst growth rate in vitro.
Considering our observations in this study, miR-182-5p should be a potential therapeutic target. We also 
observed that miR-182-5p inhibition by systemic injection of lentiviral particle-mediated inhibitory miRNA 
attenuated cyst progression in vivo. We confirmed that the expression of Wasf2, Dock1, and Itga4 were restored in 
the miR-182-5p lentivirus-injected Pkd1f/f:Aqp2-cre mice. However, miR-182-5p inhibition could not slow cyst 
growth in Pkd2f/f:Aqp2-cre mice because Wasf2, Dock1, and Itga4 play significant roles in Pkd1 but not in Pkd2 
conditional KO mice. The miRNA and its target genes, other than miR-182-5p, may play more important regula-
tory functions in Pkd2 conditional KO mice. Overall, we present strong evidence that miR-182-5p upregulation is 
Pkd1-dependently associated with defects in the actin cytoskeletal pathway, which can cause symptoms of PKD.
Figure 6. The effect of miR-182-5p inhibition in attenuating cyst growth in vivo. (A) The schedule for the 
injection study. (B) Immunofluorescence staining of kidney sections from control lentivirus- (left) or inhibitory 
miR-182-5p lentivirus- (right) injected Pkd1f/f:Aqp2-Cre mice. Red indicates collecting duct, green indicates 
proximal tubule, and blue indicates the nucleus. (C) Serum BUN levels, (D) kidney weight-to-body weight ratio, 
(E) expression of miR-182-5p and (F) expression of Wasf2, Dock1, and Itga4. n = 5, control lentivirus- and n = 6, 
inhibitory miR-182-5p lentivirus-injected mice, respectively *P < 0.05; **P < 0.01; ***P < 0.001.
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In conclusion, we applied a NGS-based methodology to identify several key miRNAs that are linked to Pkd1 
or Pkd2 expression using two ADPKD mouse models, namely, conditional Pkd1 or Pkd2-deficient mice. The 
miRNA-mRNA integrated data for cyst progression at three time-points revealed genome-wide correlations 
between molecular changes and disease phenotype. Additionally, we provided evidence of a direct link between 
the actin cytoskeleton and cystogenesis in ADPKD. Therefore, we suggest that these key miRNAs and their pos-
sible potential targets play a central role in cystogenesis in ADPKD.
Methods
Animal Models. Both the floxed Pkd1 (Pkd1flox/flox) containing loxP sites inserted in the genomic DNA 
flanking exon 2–5 of the Pkd1 gene26 and floxed Pkd2 (Pkd2flox/flox) containing loxP sites flanking exon 3 and 
4 of Pkd2 gene mice42 were obtained from Dr. Stefan Somlo at Yale University. HoxB7-Cre transgenic mice, 
which specifically drives cre expression in the kidney collecting duct, was obtained from Minho Shong at 
Chungnam National University. To characterize the phenotype resulting from Pkd1 or Pkd2 inactivation 
in the collecting duct, Pkd1f/+:HoxB7-Cre and Pkd1f/f or Pkd2f/+:HoxB7-Cre and Pkd2f/f mice were mated 
to generate a conditional knockout mouse model. Age-matched littermates with Pkd1f/f or Pkd2f/f geno-
types were used as controls. Genotyping was performed using previously described protocols26. Tail DNA 
was PCR-amplified for Pkd1f/f alleles using the forward primer 5′-CCGCTGTGTCTCAGTGCCTG-3′ 
and reverse primer 5′-CAAGAGGGCTTTTCTTGCTG-3′; for Pkd2f/f alleles using the forward primer 
5′-GGGTGCTGAAGAGATGGTTC-3′ and reverse primer 5′-TCCACAAAAGCTGCAATGAA-3′. HoxB7-cre 
transgene expression was confirmed using the forward primer 5′-GCGGTCTGGCAGTAAAAACTATC-3′ and 
reverse primer 5′-GTGAAACAGCATTGCTGTCACTT-3′. All experimental procedures were performed in 
accordance with relevant guidelines and regulations on laboratory animal care. All experimental protocols were 
reviewed and approved by the IACUC at Sookmyung Women’s University.
Cell culture and transfection. mIMCD cells were cultured in DMEM/F12 (Welgene, Korea) media with 
10% (v/v) fetal bovine serum (FBS), and 1% penicillin-streptomycin (Welgene, Korea) in a humidified 5% CO2 
atmosphere at 37 °C. Small interfering RNA (siRNA) targeting mouse Wasf2, Dock1, or Itga4 (Bioneer, Korea) 
genes were transfected into mIMCD cells at 20 nM using Lipofectamine RNAiMAX reagent (Invitrogen, 
Carlsbad, CA, USA) according to the manufacturer’s instructions for 24 to 48 h. miRNA mimics and inhibitors for 
mmu-miR-182-5p (Ambion) were reverse-transfected into mIMCD cells at 10 nM using siPORT NeoFX transfec-
tion reagent (Ambion) for 24 to 48 h. The control experiments were transfected with scramble miRNA (Pre-miR 
miRNA Precursor and miR-Vana miRNA inhibitor Molecules, Negative Control #1, Ambion).
Three-dimensional (3D) cell culture was performed according to previously reported protocol43. Briefly, sus-
pended mIMCD cells (1 × 104 cells/well) were mixed with Matrigel at a 1:1 ratio and plated in 8-well chamber 
slides. Cells in Matrigel were grown in a humidified 5% CO2 atmosphere at 37 °C for 5 days. After 5 days in 3D 
culture, phase contrast images of individual spheroids were obtained by a light microscope (IX70, Olympus) and 
cyst area was measured using ISP capture software (Olympus).
Immunostaining, immunofluorescence microscopy, and western blots. Kidneys were fixed in 
4% paraformaldehyde overnight, then paraffin-embedded. 5 μm-width sections were deparaffinized in three 
changes of xylene, followed by rehydration in an ethanol series. Sections were heated in 0.01 M citric acid (pH 
6.0) for antigen retrieval and blocked with blocking solution for 1 h at room temperature followed by overnight 
incubation with the appropriate primary antibody at 4 °C. Primary antibodies used for immunostaining were: 
Rhodamine-labeled DBA (RL-1032, Vector laboratory), Fluorescein-labeled LTL (FL-1321, Vector laboratory), 
Wasf2 (H-110, Santa Cruz Biotechnology, sc-33548), Dock1 (H-4, Santa Cruz Biotechnology, sc-13163), and 
Itga4 (H-210, Santa Cruz Biotechnology, sc-14008).
For phalloidin staining of the actin cytoskeleton in kidney tissues, tissues were fixed in 4% paraformaldehyde 
in PBS and embedded in OCT. Cryosections were blocked with 1% BSA in PBS for 1 h at room temperature and 
incubated with rhodamine-labeled phalloidin (Invitrogen, Catalog #R415) diluted 1:500 overnight at 4 °C. Slides 
were mounted using mounting medium with DAPI (Vector laboratory).
For immunocytochemistry, cultured cells were fixed in 4% paraformaldehyde for 10 min at room tempera-
ture, and then washed three times with PBS. Cells were permeabilized with 0.2% Triton X-100 containing 5% 
v/v bovine serum albumin, and incubated with the appropriate primary antibody at 4 °C overnight. Images were 
obtained with a confocal laser scanning microscope (LSM-700, Carl Zeiss).
For western blot analysis, equal amounts of protein were analyzed in duplicate by SDS-PAGE and 
electro-transferred to a polyvinylidene fluoride (PVDF) membrane (ATTO, Japan). Primary antibodies were 
diluted at 1:200~1:1000 in 1% skim milk in PBST at 4 °C overnight and secondary antibodies were incubated 
for 1 h at room temperature. Anti-β-actin (Bethyl Laboratories, Montgomery, TX, USA) was used as a loading 
control. Immunoreactive proteins were detected by horseradish peroxidase–conjugated secondary antibodies and 
enhanced using chemiluminescence (ECL) reagents (GE Healthcare Life Sciences, Piscataway, NJ).
Cystic index measurement and renal function test. The tubular cyst formation areas were quantified 
in whole kidney sections of Pkd1f/f:HoxB7-Cre and Pkd2f/f:HoxB7-Cre mice over time. Two sections from the 
mid-sagittal region of each kidney were analyzed on P1, P3, and P7 for each mouse model (n = 3). Whole kidney 
images stained with tubule markers were obtained using the scan slide module in a confocal laser scanning micro-
scope (LSM-700, Carl Zeiss). Total kidney area and cystic area with DBA signal were measured using the tools 
provided by LSM-700. The total kidney area was divided into four parts according to their sizes: non-cystic area, 
dilated tubules (<1 × 105 μm2), small cysts (1 × 105–106 μm2), and large cysts (>1 × 106 μm2). Cyst index = (total 
cystic area/total kidney area) × 100 (%).
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To investigate renal function, serum was isolated from blood samples using Vacutainers (BD Biosciences) and 
blood urea nitrogen (BUN) analysis was performed by Dr. Chulho Lee’s laboratory using a Hitachi 7150 Clinical 
Analyzer (KRIBB, Daejeon, Korea).
Small RNA and mRNA sequencing, alignment, and normalization. Total RNA was isolated using 
TRIzol according to the manufacturer’s protocol (Invitrogen Life Technologies). To estimate expression levels 
and to determine alternatively spliced transcripts, the RNA-Seq reads were mapped to the mouse genome (Mus 
musculus, version mm10) downloaded from the UCSC website (http://genome.uscs.edu) using TopHat v2.1.044, 
which is capable of reporting split-read alignments across splice junctions. Read counts of representative genes 
and their isoforms were measured by HTSeq45 with default options using RefSeq annotation as a reference. Read 
counts under ten counts in at least three samples were filtered out before normalization, and normalization was 
performed using the TMM method46. Statistical significance of the transcript expression data was determined 
with criteria (two-fold change and false discovery rate (FDR < 0.05)) from the edgeR30 Deseq231 implemented 
in the Bioconductor package. Differentially expressed genes (DEGs) were identified by pairwise comparisons 
between WT and KO groups at each time point. The DEG sets were collected for all three time points by com-
bining the lists obtained by edgeR and Deseq2. Hierarchical clustering for DEGs was performed using complete 
linkage and Euclidean distance as a measure of similarity. All statistical analysis and visualization of differentially 
expressed genes was conducted using R 3.2.3 (www.r-project.org).
For miRNA-Seq analysis, raw reads were trimmed by removing the 3′ adaptor sequence and retaining more 
than 17 bp of the read sequence. For read mapping of miRNA, trimmed reads were aligned against the mouse 
genome or aligned to the known mature & hairpin miRNAs (miRBase version 2147, June, 2014) by the miRdeep2 
program48. Raw read counts for miRNA were filtered and normalized by the same process of RNA-Seq data analy-
sis. Differentially expressed miRNAs (DEmiR) were classified as genes having a 2 fold-change and P-value < 0.05. 
The DEmiR sets were determined for all three time points by combining the lists obtained by edgeR and Deseq2.
Integration of miRNA-mRNA data. We performed mRNA-miRNA data integration for matched samples 
in each data set. First, the DEG set and miRNA set were used to calculate Spearman’s rank correlation between 
miRNA and mRNA expression in all data sets. This approach assumed that the expression of a given miRNA is 
negatively correlated with the mRNA expression of its targets. For miRNAs with the potential to regulate mRNA, 
a correlation test was performed in R to determine if the miRNA was statistically significant with a P-value < 0.05 
and a negative correlation coefficient. Then we retained putative miRNA-target mRNA pairs with a relationship 
using miRwalk v2.049 (http://zmf.umm.uni-heidelberg.de/apps/zmf/mirwalk2/), a database that supplies the larg-
est available collection of predicted and experimentally verified miRNA-target interactions.
Pathway and networking analysis. Putative target gene sets of differentially expressed miRNAs were 
evaluated by QIAGEN’s Ingenuity Pathway Analysis (IPA, QIAGEN Redwood City, www.qiagen.com/ingenuity) 
for biological functions and canonical pathways or networks. Then, we identified canonical pathways associated 
with ADPKD phenotype by identifying genes correlated with miRNAs. The network analysis tool Cytoscape 
v3.3 (http://cytoscape.org/) was used to find the putative target genes for the predicted miRNAs in canonical 
pathways. Specially, gene-gene interactions were obtained from Pathway Studio50 to identify highly connected 
modules within a canonical pathway.
Quantitative real-time RT-PCR. To detect mRNA expression, total RNA (2 μg) was reverse-transcribed 
using M-MLV Reverse Transcriptase (Promega), 100 nM oligo-dT, 1 mM dNTP mixture, and RNase inhibi-
tor. Mouse 18S rRNA, detected with the forward primer 5′-GTAACCCGTTGAACCCCATT-3′ and reverse 
5′-CCATCCAATCGGTAGTAGCG-3′, was used as an endogenous control. Quantitative real-time PCR was per-
formed using the real-time SensiMixPlus SYBR kit as described in the manufacturer’s instructions (Quantance, 
London, UK).
To detect miRNA expression, cDNA was prepared from total RNA (500 ng) using a miScript II RT kit (Qiagen) 
according to the manufacturer’s protocol. Real-time PCR quantification of mature miRNA was performed using 
target-specific miScript Primer Assays (Qiagen) and the miScript SYBR Green PCR Kit (Qiagen) according to the 
manufacturer’s protocol.
3′UTR reporter analysis. The 3′UTR of mmu-miR-182-5p candidate target mRNAs were amplified by PCR 
using PrimeSTAR GXL DNA polymerase (Takara Bio Inc., Japan) and cloned into the XhoI and NotI site of a 
psiCHECK-2 vector (Promega) using an In-Fusion HD Cloning kit (Takara Bio Inc., Japan). The seed sequences 
of miR-182-5p were mutated using a PCR-based approach. For transfection, mIMCD cells (2 × 105) were plated 
into 6-well plates and 1.5 μg of luciferase constructs and 15 nM of negative control mimics or mmu-miR-182-5p 
mimics (Ambion) were co-transfected into the cells one day after seeding using Lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s instruction. Cells were collected after 36 h for experiments and luciferase activity 
was measured by a Dual Luciferase Assay system (Promega). All transfection experiments were performed in 
triplicate and at least three times.
Section microRNA in situ hybridization. Kidneys were dissected at postnatal day 7 and subsequently 
fixed in 4% paraformaldehyde (PFA) overnight. After fixation, tissues were embedded in paraffin and sectioned 
at a thickness of 7 μm. Sections were incubated at 60 °C for deparaffinization using Histoclear II (National 
Diagnostics), re-hydrated through a graded series of alcohol washes and 1X DEPC-PBS. The specimens were 
treated with 10 μg/ml proteinase K for 5 min at 37 °C. Sections were incubated in pre-hybridization buffer (50% 
formamide, 5× SSC, 0.1% Tween-20, 50 ug/ml heparin, 500 ug/ml yeast tRNA) at 53 °C for 1 hr. Hybridization 
was conducted at 53 °C for overnight using miR-182 locked nucleic acid (LNA) modified probe (Exiqon). Sites of 
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hybridization were detected using alkaline phosphatase-conjugated DIG antibody (Roch) at a 1:1,000 dilutions, 
RT for overnight, followed by NBT/BCIP AP substrate color development (Roche).
Statistical analysis. Each experiment was repeated at least three times throughout the study. Data were 
reported as means ± SD. Statistical significance was determined by Student’s t-tests when only two groups were 
compared (GraphPad Software, San Diego, CA). P < 0.05 was considered significant.
Accession codes. mRNA and Small RNA sequencing data have been deposited in the NCBI’s Gene 
Expression Omnibus (GEO) Database under the accession code GSE86509 and in the Korean Bioinformation 
Center (KOBIC)’s database under the accession codes KBRS20160928_0000001 ~ KBRS20160928_0000072.
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